239 related articles for article (PubMed ID: 28389630)
1. Identification of small molecule inhibitors of the Aurora-A/TPX2 complex.
Asteriti IA; Daidone F; Colotti G; Rinaldo S; Lavia P; Guarguaglini G; Paiardini A
Oncotarget; 2017 May; 8(19):32117-32133. PubMed ID: 28389630
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis.
Gupta A; Jain R; Wahi D; Goyal S; Jamal S; Grover A
J Recept Signal Transduct Res; 2015; 35(6):626-33. PubMed ID: 26390942
[TBL] [Abstract][Full Text] [Related]
3. A TPX2 Proteomimetic Has Enhanced Affinity for Aurora-A Due to Hydrocarbon Stapling of a Helix.
Rennie YK; McIntyre PJ; Akindele T; Bayliss R; Jamieson AG
ACS Chem Biol; 2016 Dec; 11(12):3383-3390. PubMed ID: 27775325
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.
McIntyre PJ; Collins PM; Vrzal L; Birchall K; Arnold LH; Mpamhanga C; Coombs PJ; Burgess SG; Richards MW; Winter A; Veverka V; Delft FV; Merritt A; Bayliss R
ACS Chem Biol; 2017 Nov; 12(11):2906-2914. PubMed ID: 29045126
[TBL] [Abstract][Full Text] [Related]
5. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
Panicker RC; Coyne AG; Srinivasan R
Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768
[TBL] [Abstract][Full Text] [Related]
6. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity.
Grover A; Singh R; Shandilya A; Priyandoko D; Agrawal V; Bisaria VS; Wadhwa R; Kaul SC; Sundar D
PLoS One; 2012; 7(1):e30890. PubMed ID: 22303466
[TBL] [Abstract][Full Text] [Related]
7. Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.
Cole DJ; Janecek M; Stokes JE; Rossmann M; Faver JC; McKenzie GJ; Venkitaraman AR; Hyvönen M; Spring DR; Huggins DJ; Jorgensen WL
Chem Commun (Camb); 2017 Aug; 53(67):9372-9375. PubMed ID: 28787041
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2.
Zorba A; Buosi V; Kutter S; Kern N; Pontiggia F; Cho YJ; Kern D
Elife; 2014 May; 3():e02667. PubMed ID: 24867643
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.
Janeček M; Rossmann M; Sharma P; Emery A; Huggins DJ; Stockwell SR; Stokes JE; Tan YS; Almeida EG; Hardwick B; Narvaez AJ; Hyvönen M; Spring DR; McKenzie GJ; Venkitaraman AR
Sci Rep; 2016 Jun; 6():28528. PubMed ID: 27339427
[TBL] [Abstract][Full Text] [Related]
10. Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states.
Lake EW; Muretta JM; Thompson AR; Rasmussen DM; Majumdar A; Faber EB; Ruff EF; Thomas DD; Levinson NM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11894-E11903. PubMed ID: 30518564
[TBL] [Abstract][Full Text] [Related]
11. Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2.
Chen H; Mohan P; Jiang J; Nemirovsky O; He D; Fleisch MC; Niederacher D; Pilarski LM; Lim CJ; Maxwell CA
Cell Cycle; 2014; 13(14):2248-61. PubMed ID: 24875404
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of specific binding between Aurora A and TPX2 by molecular dynamics simulations.
Cheng Y; Zhang F; Chen Q; Gao J; Cui W; Ji M; Tung CH
J Chem Inf Model; 2011 Oct; 51(10):2626-35. PubMed ID: 21919471
[TBL] [Abstract][Full Text] [Related]
13. Control of Aurora-A stability through interaction with TPX2.
Giubettini M; Asteriti IA; Scrofani J; De Luca M; Lindon C; Lavia P; Guarguaglini G
J Cell Sci; 2011 Jan; 124(Pt 1):113-22. PubMed ID: 21147853
[TBL] [Abstract][Full Text] [Related]
14. Binding of TPX2 to Aurora A alters substrate and inhibitor interactions.
Anderson K; Yang J; Koretke K; Nurse K; Calamari A; Kirkpatrick RB; Patrick D; Silva D; Tummino PJ; Copeland RA; Lai Z
Biochemistry; 2007 Sep; 46(36):10287-95. PubMed ID: 17705509
[TBL] [Abstract][Full Text] [Related]
15. Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes.
Lee SY; Kim EY; Kim KH; Lee KA
Cell Cycle; 2016 Dec; 15(23):3296-3305. PubMed ID: 27753540
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism for activation of the protein kinase Aurora A.
Eyers PA; Erikson E; Chen LG; Maller JL
Curr Biol; 2003 Apr; 13(8):691-7. PubMed ID: 12699628
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle.
Bayliss R; Sardon T; Vernos I; Conti E
Mol Cell; 2003 Oct; 12(4):851-62. PubMed ID: 14580337
[TBL] [Abstract][Full Text] [Related]
18. Activation of Aurora-A kinase by protein partner binding and phosphorylation are independent and synergistic.
Dodson CA; Bayliss R
J Biol Chem; 2012 Jan; 287(2):1150-7. PubMed ID: 22094468
[TBL] [Abstract][Full Text] [Related]
19. AurkA/TPX2 co-overexpression in nontransformed cells promotes genome instability through induction of chromosome mis-segregation and attenuation of the p53 signalling pathway.
Naso FD; Polverino F; Cilluffo D; Latini L; Stagni V; Asteriti IA; Rosa A; Soddu S; Guarguaglini G
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167116. PubMed ID: 38447882
[TBL] [Abstract][Full Text] [Related]
20. The nuclear scaffold protein SAF-A is required for kinetochore-microtubule attachment and contributes to the targeting of Aurora-A to mitotic spindles.
Ma N; Matsunaga S; Morimoto A; Sakashita G; Urano T; Uchiyama S; Fukui K
J Cell Sci; 2011 Feb; 124(Pt 3):394-404. PubMed ID: 21242313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
